6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one

Catalog No. :
ACGOXY706
CAS No. :
33050-32-7
Molecular Formula :
C5H3ClN4O
Molecular Weight :
170.56

IUPAC Name:6-chloro-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one

6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$124.00Login to see priceIn stockIn stock
10g95%$246.00Login to see priceIn stockIn stock
25g95%$544.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
IUPAC Name6-chloro-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
MDL No.MFCD01219639
Molecular FormulaC5H3ClN4O
Molecular Weight170.56
SMILESO=C1NN=C2C=CC(Cl)=NN21
InChI KeyOXXDECZCLRNVKK-UHFFFAOYSA-N
SynonymMFCD01219639 | BBL009690 | 6-chloro-2H-[1,2,4]triazolo[4,3-b]pyridazin-3-one | OXXDECZCLRNVKK-UHFFFAOYSA-N | AMY31816 | 3-hydroxy-6-chloro-1,2,4-triazolo[4,3-b]pyridazine | 6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one | 6-chloro[1,2,4]triazolo[4,3-b
CAS No.33050-32-7
PubChem CID6407182

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H332-H315-H319-H335
Precautionary Statement(s)
P301+P310-P304+P340-P305+P351+P338

Synthetic Route by SureRoute

1. ACGOXY706 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACGOXY706 route product structure diagram
    ACGOXY70633050-32-7 In Stock
Inquiry

2. ACGOXY706 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGOXY706 route product structure diagram
    ACGOXY70633050-32-7 In Stock
Inquiry

Comments (0)